The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling

Sushmita Maitra1, Rima M Kulikauskas, Heather Gavilan

  • 1Department of Molecular Genetics and Cell Biology, University of Chicago, Illinois 60637, USA.

Current Biology : CB
|April 4, 2006
PubMed

Insights

The Drosophila tumor suppressors Merlin (Mer) and Expanded (ex) regulate cell proliferation by controlling cell-surface receptor levels. Loss of Mer and ex leads to hyperactivated signaling pathways due to defective receptor clearance.

Area of Science:

  • Cell Biology
  • Developmental Biology
  • Molecular Biology

Background:

  • Precise signal coordination is crucial for tissue growth regulation.
  • Receptor localization, compartmentalization, and trafficking significantly impact signaling in developing tissues.
  • The roles of Merlin (Mer) and Expanded (ex) in regulating proliferation and differentiation in imaginal epithelia are investigated.

Purpose of the Study:

  • To elucidate the mechanism by which Drosophila tumor suppressors Merlin and Expanded regulate proliferation and differentiation.
  • To understand how these FERM domain proteins affect signaling and adhesion receptors.
  • To investigate the impact of Merlin and Expanded on receptor turnover and cell surface dynamics.

Main Methods:

  • Examined the mechanism of Merlin and Expanded in Drosophila imaginal epithelia.
  • Assessed the steady-state levels of signaling and adhesion receptors.
  • Utilized pulse-chase labeling of Notch in living tissues to study receptor turnover.

Main Results:

  • Merlin and Expanded regulate steady-state levels of signaling and adhesion receptors.
  • Loss of Merlin and Expanded leads to hyperactivation of associated signaling pathways.
  • Mer; ex double mutant cells exhibit upregulated cell-surface receptor levels due to impaired receptor clearance.

Conclusions:

  • Merlin and Expanded control tissue proliferation by regulating the abundance, localization, and turnover of cell-surface receptors.
  • Misregulation of these receptor dynamics is implicated in tumorigenesis.
  • These findings provide insights into the molecular mechanisms underlying growth control and cancer development.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...